Iberian private equity investor GED Capital has bought four businesses through its GED VI España fund to create a new platform company of integrated services providers covering the needs of the whole drug life cycle.
Abris Capital Partners has agreed a buyout of Polish healthcare network operator Scanmed from Life Healthcare Group.
Four private equity majors have been shortlisted by fellow buyout house Advent as it looks to sell Dutch medical supplier Mediq in a deal which could exceed €1bn.
Warburg Pincus' former global healthcare head is out eyeing up to $300m for the debut fundraise from his firm Ascend Partners.
Stockholm's Summa Equity has bought a majority stake in protein production and research specialist Sengenics through its €610m second fund.
VSS Capital Partners has made podiatry practice management business Podiatry Growth Partners its latest investment.
European life sciences investor Medicxi has hit a €200m final close for its debut secondaries fund amid using the vehicle to pick up six companies from one of the firm's previous funds.
Philadelphia private equity house Renovus Capital Partners has agreed to sell medical simulation solutions provider EMS to trade player Collegis after six years in its portfolio.
One Equity Partners has picked up advanced wound care and medical procedure supplies and services company American Medical Technologies.
Capricorn Venture Partners has made the second investment from its Digital Growth Fund by backing the €38m Series B round for medical device business Indigo Diabetes.
Blackstone has raised $4.6bn for the biggest-ever private equity fund dedicated to life sciences investments, hitting its hard cap for the vehicle.
New Nordic life sciences venture capital investor Eir Ventures has hit a €76m first close for its debut fundraise.
SilverConnect, a medical nutrition startup creating specialized food solutions for people with difficulty swallowing, has closed a seed financing round led by Heritas Capital Management.
Swiss contract research, development and manufacturing specialist Solvias has been bought by JLL Partners and Water Street Partners.
Spanish early stage investment house Ysios Capital has hit €155m for its third life science fund - and could go as high as €200m for the vehicle.
